The effect of Iranian traditional medicine on IBS disease
- Conditions
- Irritable bowel syndrome with constipation prevalence.Irritable bowel syndrome
- Registration Number
- IRCT2017061034446N1
- Lead Sponsor
- Deputy of Research and Technology, Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
The criteria for entry are based on the diagnostic criteria of IBS, namely, ROME IV, which is as follows:
(Recurrent abdominal pain at least one day a week in the last three months, with at least two of the following three characteristics: related to bowel movements - with a change in the frequency of bowel movements - accompanied by changes in the shape of the stool These symptoms start at least six months before the diagnosis.); constipation based on Bristrol Stool Form Scale; age between 18-50 years old; not having severe mental and behavioral disorders; no history of organic bowel disease; lack of pregnancy or breastfeeding; lack of drug addiction; no history of any major bowel surgery; serious and malignant systemic disease; the inability to use interfering chemical and vegetable medications with treatment.
Exit criteria:
pregnancy during the study; in the event of drug complications or other medical problems; unwillingness to continue treatment.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of disease, stool consistency,. Timepoint: At the beginning of the study and before starting treatment. Method of measurement: Illness severity questionnaire - IBS-SSS and Bristrol Stool Form Scale.
- Secondary Outcome Measures
Name Time Method Anxiety and depression. Timepoint: 6 weeks after starting treatment and 4 weeks after treatment. Method of measurement: questionnaire severity of depression and anxiety-HADS-.